The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Five-Year Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: The Prostate Cancer Outcomes Study
Abstract
BACKGROUND: Men treated for clinically localized prostate cancer with either radical prostatectomy or external beam radiotherapy usually survive many years with the side effects of these treatments. We present treatment-specific quality-of-life outcomes for prostate cancer patients 5 years after initial diagnosis. METHODS: The cohort consisted of men aged 55-74 years who were newly diagnosed with clinically localized prostate cancer in 1994-1995 and were treated with radical prostatectomy (n = 901) or external beam radiotherapy (n = 286). We used clinical and quality-of-life data previously collected at the time of diagnosis (i.e., baseline) and at the 2-year follow-up and data newly collected at 5 years after diagnosis to compare urinary, bowel, and sexual function and to examine temporal changes in those functions. Odds ratios (ORs) and adjusted percentages were calculated by logistic regression. All statistical tests were two-sided. RESULTS: At 5 years after diagnosis, overall sexual function declined in both groups to approximately the same level. However, at 5 years after diagnosis, erectile dysfunction was more prevalent in the radical prostatectomy group than in the external beam radiotherapy group (79.3% versus 63.5%; OR = 2.5, 95% confidence interval [CI] = 1.6 to 3.8). Approximately 14%-16% of radical prostatectomy and 4% of external beam radiotherapy patients were incontinent at 5 years (OR = 4.4, 95% CI = 2.2 to 8.6). Bowel urgency and painful hemorrhoids were more common in the external beam radiotherapy group than in the radical prostatectomy group. All of these differences remained statistically significant after adjustment for confounders and for differences between treatment groups in some baseline characteristics. CONCLUSIONS: At 5 years after diagnosis, men treated with radical prostatectomy for localized prostate cancer continue to experience worse urinary incontinence than men treated with external beam radiotherapy. However, the two treatment groups were more similar to each other with respect to overall sexual function, mostly because of a continuing decline in erectile function among the external beam radiotherapy patients between years 2 and 5.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For early stage cancer, primary treatment options are radical prostatectomy, radiation therapy, and active surveillance, which can lead to differences in specific areas of functioning, such as sexual, urinary or bowel functioning over time [2, 3].”
From Prostate cancer: Psychosocial implications and management (2008) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
McHorney, C. A., Ware, J. E., Rachel Lu, J. F., & Sherbourne, C. D. (1994) · Medical Care · doi:10.1097/00005650-199401000-00004 · Cited by 4,458
Estimating Causal Effects from Large Data Sets Using Propensity Scores
Rubin, D. V. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00064 · Cited by 3,104
Reducing Bias in Observational Studies Using Subclassification on the Propensity Score
Rosenbaum, P. R., & Rubin, D. B. (1984) · Journal of the American Statistical Association · doi:10.1080/01621459.1984.10478078 · Cited by 3,082
Urinary and Sexual Function After Radical Prostatectomy for Clinically Localized Prostate Cancer
Stanford, J. L., Feng, Z., Hamilton, A. S., Gilliland, F. D., Stephenson, R. A., Eley, J. W., Albertsen, P. C., Harlan, L. C., & Potosky, A. L. (2000) · JAMA · doi:10.1001/jama.283.3.354 · Cited by 1,187
Self-citationPredictive Margins with Survey Data
Graubard, B. I., & Korn, E. L. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00652.x · Cited by 875
The UCLA Prostate Cancer Index
Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., LEAKE, B. D., & Brook, R. H. (1998) · Medical Care · doi:10.1097/00005650-199807000-00007 · Cited by 819
A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer
Holmberg, L., Bill‐Axelson, A., Helgesen, F., Salo, J. O., Folmerz, P., Häggman, M., Andersson, S., Spångberg, A., Busch, C., Nordling, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012794 · Cited by 809
Quality of Life after Radical Prostatectomy or Watchful Waiting
Steineck, G., Helgesen, F., Adolfsson, J., Dickman, P. W., Johansson, J., Norlén, B. J., & Holmberg, L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021483 · Cited by 710
Fleming, C. (1993) · JAMA · doi:10.1001/jama.269.20.2650 · Cited by 565
Research works printed but not linked: 1
- Fleming, 1993, JAMA, 269, 2650, 10.1001/jama.1993.03500200064035 · DOI · Paper page
Cited by
Sorted by citations
Items 301–400 of 679
Using patient‐reported outcomes to assess and improve prostate cancer brachytherapy
Talcott, J. A., Manola, J. B., Chen, R. C., Clark, J. A., Kaplan, I. D., D'Amico, A. V., & Zietman, A. L. (2013) · British Journal of Urology · doi:10.1111/bju.12464 · Cited by 17
Jessen, K., Søndergaard, J., Larsen, P. V., & Thomsen, J. L. (2013) · International Journal of Family Medicine · doi:10.1155/2013/540707 · Cited by 16
Interpositional Nerve Grafting of the Prostatic Plexus after Radical Prostatectomy
Kung, T. A., Waljee, J. F., Curtin, C. M., Wei, J. T., Montie, J. E., & Cederna, P. S. (2015) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000000422 · Cited by 16
Andiç, F., İzol, V., Gökçay, S., Arslantaş, H. S., Bayazıt, Y., Coskun, H., Tansuğ, M. Z., & Sertdemır, Y. (2019) · BMC Urology · doi:10.1186/s12894-018-0432-6 · Cited by 16
Advances in localized prostate cancer: A special focus on photothermal therapy
Pinho, S., Coelho, J. M. P., Gaspar, M. M., & Reis, C. P. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176982 · Cited by 17
Budäus, L., Huland, H., & Graefen, M. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.09.004 · Cited by 16
Hoffman, R. M. (2012) · JNCI Monographs · doi:10.1093/jncimonographs/lgs023 · Cited by 16
Self-citationMagnetic Resonance–Guided Thermal Therapy for Localized and Recurrent Prostate Cancer
Woodrum, D. A., Kawashima, A., Gorny, K. R., & Mynderse, L. A. (2015) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2015.05.014 · Cited by 16
Cronin, P., Kirkbride, B., Bang, A., Parkinson, B., Smith, D. P., & Haywood, P. (2016) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12582 · Cited by 16
Davis, K., Dawson, D., Kelly, S. P., Red, S. N., Penek, S., Lynch, J. J., Collins, S., Lynch, B., Porrazzo, M., Bass, M., et al. (2013) · The Journal of Supportive Oncology · doi:10.12788/j.suponc.0013 · Cited by 16
Newton, R. U., Christophersen, C. T., Fairman, C. M., Hart, N. H., Taaffe, D. R., Broadhurst, D., Devine, A., Chee, R., Tang, C., Spry, N. A., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024872 · Cited by 16
Variation in communication of side effects in prostate cancer treatment consultations
Daskivich, T. J., Naser‐Tavakolian, A., Gale, R., Luu, M., Friedrich, N. A., Venkataramana, A., Khodyakov, D., Posadas, E. M., Sandler, H. M., Spiegel, B. M. R., et al. (2024) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-024-00806-2 · Cited by 15
Kimura, M., Zodda, A. R., Mahmood, J., Das, S. K., Nguyen, G. B., Jackson, I. L., & Vujašković, Ž. (2015) · Urology · doi:10.1016/j.urology.2014.12.020 · Cited by 15
Mood outcomes of a behavioral treatment for urinary incontinence in prostate cancer survivors
Zhang, A. Y., Ganocy, S., Fu, A., Kresevic, D., Ponsky, L., Strauss, G. J., Bodner, D., & Zhu, H. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04745-w · Cited by 16
Storås, A. H., Sanda, M. G., Ferrer, M., Loge, J. H., Dahl, A. A., Steinsvik, E. A. S., Guedea, F., Cvancarova, M., & Fosså, S. D. (2014) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2013.12.007 · Cited by 15
Cruess, D. G., Benedict, C., Lattie, E. G., Molton, I. R., Kinsinger, D., Kava, B., Manoharan, M., Soloway, M. S., & Penedo, F. J. (2012) · Journal of Personality Assessment · doi:10.1080/00223891.2012.681819 · Cited by 15
Urinary, sexual, and bowel dysfunction and bother after radical prostatectomy.
Weber, B. A., Roberts, B. L., Chumbler, N. R., Mills, T. L., & Algood, C. B. (2007) · PubMed · Cited by 15
Sexual dysfunction in cancer patients: a review.
Çakar, B., Karaca, B., & Uslu, R. (2013) · PubMed · Cited by 15
Chen, C., Chen, Z., Wang, K., Hu, L., Xu, R., & He, X. (2017) · Oncotarget · doi:10.18632/oncotarget.21519 · Cited by 15
How, why and when should urologists evaluate male sexual function?
Droupy, S., Ponsot, Y., & Giuliano, F. (2006) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0406 · Cited by 15
Minimally Invasive Approaches to Localized Prostate Carcinoma
Grubb, R. L., Vardi, I. Y., Bhayani, S. B., & Kibel, A. S. (2006) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2006.03.008 · Cited by 15
Collagen-based materials in male genitourinary diseases and tissue regeneration
Li, F., XinHuang, Wang, R., Li, Y., Wu, L., Qiao, X., Zhong, Y., Gong, G., & Huang, W. (2024) · Collagen and Leather · doi:10.1186/s42825-024-00185-3 · Cited by 15
Gjerset, G. M., Fosså, S. D., Dahl, A. A., Loge, J. H., Ensby, T., & Thorsen, L. (2011) · Journal of Cancer Education · doi:10.1007/s13187-011-0245-8 · Cited by 14
Yates, D. R., & Anderson, J. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2864-9_27 · Cited by 14
Cantlay, A., & Raghallaigh, H. N. (2015) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738014568038 · Cited by 14
External Beam Radiotherapy as Curative Treatment of Prostate Cancer
Pisansky, T. M. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.7.883 · Cited by 14
Jaja, C., Parés, A. R., Wolpin, S. E., & Berry, D. L. (2010) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30601-5 · Cited by 14
Vij, A., Kowalkowski, M. A., Hart, T. L., Goltz, H. H., Hoffman, D. J., Knight, S. J., Caroll, P. R., & Latini, D. M. (2013) · Journal of Cancer Education · doi:10.1007/s13187-013-0538-1 · Cited by 13
Shen, C., Jain, K., Shah, T., Schaefer, É., Zhou, S., Fried, D. A., Helmer, D. A., & Sadeghi‐Nejad, H. (2022) · Korean journal of urology · doi:10.4111/icu.20210445 · Cited by 13
Robinson, J. P., Bradway, C. W., Nuamah, I. F., Pickett, M., & McCorkle, R. C. (2008) · International Journal of Urological Nursing · doi:10.1111/j.1749-771x.2007.00033.x · Cited by 13
Radical Prostatectomy for High-risk Localized or Node-Positive Prostate Cancer: Removing the Primary
Matulay, J. T., & DeCastro, G. J. (2017) · Current Urology Reports · doi:10.1007/s11934-017-0703-x · Cited by 13
Nanton, V., Appleton, R., Dale, J. R., Roscoe, J., Hamborg, T., Ahmedzai, S. H., Arvanitis, T. N., Badger, D., James, N. D., Mendelsohn, R. A., et al. (2017) · JMIR Research Protocols · doi:10.2196/resprot.7667 · Cited by 13
Roviello, G., Corona, S. P., Bonetta, A., Cappelletti, M. R., & Generali, D. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s143020 · Cited by 13
Liu, R., Lianzhong, Z., Duan, M. S., Cao, G., 曹广劭, Zhiyang, C., Ye, Z., Wu, Y., Yuejin, W., & Liu, L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0223229 · Cited by 13
Dehn, T. (2006) · Annals of The Royal College of Surgeons of England · doi:10.1308/003588406x117133 · Cited by 13
Reproductive Complications and Sexual Dysfunction in Cancer Survivors
Schover, L. R. (2007) · Springer eBooks · doi:10.1007/978-0-387-68265-5_19 · Cited by 13
In regard to Kagan: “The multidisciplinary clinic” (Int J Radiat Oncol Biol Phys 2005;61:967–968)
Valdagni, R., Salvioni, R., Nicolai, N., Villa, S., Bedini, N., Bajetta, E., Procopio, G., Donegani, S., & Bosisio, M. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.04.055 · Cited by 13
Gravina, G. L., Tombolini, V., Staso, M. D., Franzese, P., Bonfili, P., Gennarelli, A., Nicola, L. D., Masciocchi, C., & Cesare, E. D. (2012) · European Radiology · doi:10.1007/s00330-012-2546-7 · Cited by 12
The Relationship Between Clinical Benefit and Receipt of Curative Therapy for Prostate Cancer
Raldow, A. C. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.1494 · Cited by 12
The utility of magnetic resonance imaging in prostate cancer diagnosis in the Australian setting
Tay, J., Chow, K., Gavin, D. J., Mertens, E., Howard, N., Thomas, B., Dundee, P. E., Peters, J. S., Simkin, P. M., Kranz, S., et al. (2021) · BJUI Compass · doi:10.1002/bco2.99 · Cited by 12
Beatty, J. D. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.09112_1.x · Cited by 12
Zeliadt, S. B., Hannon, P. A., TRIVEDI, R. B., Bonner, L. M., Vu, T. T., Simons, C. E., Kimmie, C., Hu, E., Zipperer, C., & Lin, D. W. (2013) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-13-19 · Cited by 12
Targeted prostate biopsy and MR-guided therapy for prostate cancer
Woodrum, D. A., Kawashima, A., Gorny, K. R., & Mynderse, L. A. (2016) · Abdominal Radiology · doi:10.1007/s00261-016-0681-3 · Cited by 12
Skolarus, T. A., Metreger, T., Hwang, S., Kim, H. M., Grubb, R. L., Gingrich, J. R., & Hawley, S. T. (2017) · Trials · doi:10.1186/s13063-017-1925-4 · Cited by 12
MR-Guided Prostate Interventions
Woodrum, D. A., Górny, K., & Mynderse, L. A. (2018) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0000000000000155 · Cited by 12
Barrado, M., Blanco‐Luquin, I., Navarrete, P. A., Visus, I., Guerrero‐Setas, D., Escors, D., Kochan, G. T., & Arias, F. (2019) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2019.02.002 · Cited by 12
Randomized trial results did not resolve controversies surrounding prostate cancer screening
Hoffman, R. M. (2010) · Current Opinion in Urology · doi:10.1097/mou.0b013e3283383b55 · Cited by 12
Self-citationSocial and clinical predictors of prostate cancer treatment decisions among men in South Carolina
Wagner, S. E., Drake, B. F., Elder, K. T., & Hébert, J. R. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9836-2 · Cited by 12
Newton, F. J., Burney, S., Millar, J. L., Frydenberg, M., & Ng, K. T. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06152.x · Cited by 12
Localized Prostate Cancer: Quality of Life Meets Whitmore's Legacy
Bermejo, C., Kristal, A. R., Zeliadt, S. B., Ramsey, S. D., & Thompson, I. M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh282 · Cited by 12
Functional Outcomes after Treatment for Prostate Cancer
Rocco, B., LORENZIS, E. D., & Palumbo, C. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1302509 · Cited by 12
Ranasinghe, W., de Silva, D., Bandaragoda, T., Adikari, A., Alahakoon, D., Persad, R., Lawrentschuk, N., & Bolton, D. (2018) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2018.08.012 · Cited by 21
Image-Guided Prostate Cryoablation: State-of-the-Art
Ramalingam, V., McCarthy, C. J., Degerstedt, S. G., & Ahmed, M. (2023) · Medicina · doi:10.3390/medicina59091589 · Cited by 11
Bakan, J., Chen, B., Medeiros-Nancarrow, C., Hu, J. C., Kantoff, P. W., & Recklitis, C. J. (2013) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2013.11.005 · Cited by 11
Shen, X., Zaorsky, N. G., Mishra, M. V., Foley, K. A., Hyslop, T., Hegarty, S., Pizzi, L. T., Dicker, A. P., & Showalter, T. N. (2011) · Future Oncology · doi:10.2217/fon.11.131 · Cited by 11
Petersen, S. E., Bregendahl, S., Langschwager, M., Laurberg, S., Brock, C., Drewes, A. M., Krogh, K., Høyer, M., & Lundby, L. (2014) · Acta Oncologica · doi:10.3109/0284186x.2014.926029 · Cited by 11
Ciabatti, S., Ntreta, M., Buwenge, M., Gaudiano, C., Sessagesimi, E., Romani, F., Angelini, A. L., Cammelli, S., Macchia, G., Deodato, F., et al. (2019) · Medical dosimetry · doi:10.1016/j.meddos.2019.01.008 · Cited by 11
Prostate cancer survivorship care in the Veterans Health Administration.
Skolarus, T. A., & Hawley, S. T. (2014) · PubMed · Cited by 11
Sundaram, K. M., Staruch, R., Burtnyk, M., Lane, J., Penson, D. F., & Arora, S. (2020) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2019.12.802 · Cited by 11
Self-citationPrevalence of Erectile Dysfunction in Men Screened for Prostate Cancer
Bianco, F. J., McHone, B., Wagner, K., King, A., Burgess, J., Patierno, S., & Jarrett, T. W. (2009) · Urology · doi:10.1016/j.urology.2008.03.036 · Cited by 11
Krouwel, E. M., Palacios, L. A. G., Putter, H., Pelger, R. C. M., Kloens, G. J., & Elzevier, H. W. (2016) · Urology · doi:10.1016/j.urology.2015.10.048 · Cited by 11
Leal, F. R. P., de Figueiredo, M. A. N., & Sasse, A. D. (2015) · International braz j urol · doi:10.1590/s1677-5538.ibju.2014.0412 · Cited by 11
Dale, W., Bilir, S. P., Hemmerich, J. A., Basu, A., Elstein, A. S., & Meltzer, D. O. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181f37bf2 · Cited by 11
State-Level Cancer Quality Assessment and Research
Lipscomb, J., & Gillespie, T. W. (2011) · The Cancer Journal · doi:10.1097/ppo.0b013e3182296422 · Cited by 10
Radiation therapy for prostate cancer: What’s the best in 2021
Cellini, F., Tagliaferri, L., Frascino, V., Alitto, A. R., Fionda, B., Boldrini, L., Romano, A., Casà, C., Catucci, F., Mattiucci, G. C., et al. (2021) · Urologia Journal · doi:10.1177/03915603211042335 · Cited by 10
Valderrábano, R. J., Pencina, K. M., Storer, T. W., Reid, K. F., Kibel, A. S., Burnett, A. L. “., Huang, G. T.-W., Dorff, T. B., Privat, F., Ghattas, C., et al. (2022) · Andrology · doi:10.1111/andr.13299 · Cited by 10
Erectile Dysfunction in Pelvic Cancer Survivors and Current Management Options
Bernal, J. O., Venkatesan, K., & Martins, F. E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072697 · Cited by 10
Cancer Screenings, Diagnostic Technology Evolution, and Cancer Control
Stracci, F. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-416-2_6 · Cited by 10
Weersink, R., Chaudhary, S., Mayo, K., He, J., & Wilson, B. C. (2017) · Journal of Biomedical Optics · doi:10.1117/1.jbo.22.4.045004 · Cited by 10
Availability of Public Toilets in Parks and Recreational Sites in Selected US Cities
Park, Y. S., & Bliss, D. Z. (2019) · Journal of Wound Ostomy and Continence Nursing · doi:10.1097/won.0000000000000522 · Cited by 10
Qualité de vie après radiothérapie pour un cancer localisé de la prostate
Joly, F., Degrendel, A.-C., & Guizard, A. (2010) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2010.06.015 · Cited by 10
Otero, J., & Martínez‐Salamanca, J. I. (2007) · Archivos Españoles de Urología · doi:10.4321/s0004-06142007000700006 · Cited by 10
Recall of pretreatment symptoms among men treated with radiotherapy for prostate cancer
Fransson, P. (2005) · Acta Oncologica · doi:10.1080/02841860510029806 · Cited by 10
Prostate Cancer Quality of Life: Beyond Initial Treatment—and the Patient
Talcott, J. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.1996 · Cited by 10
Longitudinal assessment of BMI in relation to ADT use among early stage prostate cancer survivors
Beehler, G. P., Wade, M. J., Kim, B., Steinbrenner, L. M., & Wray, L. O. (2009) · Journal of Cancer Survivorship · doi:10.1007/s11764-009-0099-9 · Cited by 9
Perioperative infection prevention during inflatable penile prosthesis surgery: a narrative review
Matthew-Onabanjo, A. N., Matthew, A. N., Famati, E., Nguyen, V., & Rogers, M. J. (2024) · Translational Andrology and Urology · doi:10.21037/tau-23-497 · Cited by 9
Biran, A., Bolnykh, I., Rimmer, B., Cunliffe, A., Durrant, L., Hancock, J., Ludlow, H., Pedley, I. D., Rees, C. J., & Sharp, L. (2023) · Cancers · doi:10.3390/cancers15164037 · Cited by 9
He, J., Wilson, B. C., Piao, D. D., & Weersink, R. (2014) · Photonics and Lasers in Medicine · doi:10.1515/plm-2014-0011 · Cited by 9
Palacios, L. A. G., Krouwel, E. M., Duijn, M., Oudsten, B. L. D., den Ouden, M. E. M., Putter, H., Pelger, R. C. M., & Elzevier, H. W. (2016) · European Journal of Cancer Care · doi:10.1111/ecc.12629 · Cited by 9
Cribbs, K. A., Manning, E. F., Zhou, J., Lahue, B. J., & Polascik, T. J. (2023) · Urology · doi:10.1016/j.urology.2023.01.024 · Cited by 9
Mathiéu, R., Fegoun, A. B. E., Azzouzi, A.-R., Campeggi, A., Cornu, J., Delongchamps, N. B., Dumonceau, O. O., Faix, A., Fourmarier, M., Haillot, O., et al. (2013) · The French Journal of Urology · doi:10.1016/j.purol.2013.11.011 · Cited by 9
Quality of Life for Men Receiving a Second Treatment for Prostate Cancer
Arredondo, S. A., Latini, D. M., Sadetsky, N., Kawakami, J., Pasta, D. J., DuChane, J., Carroll, P. R., & CaPSURE Investigators (2006) · The Journal of Urology · doi:10.1016/j.juro.2006.08.061 · Cited by 9
Shifting focus to cancer survivorship in prostate cancer: challenges and opportunities
Gilbert, S. M. (2008) · Current Opinion in Urology · doi:10.1097/mou.0b013e3282f9b3ff · Cited by 9
Postoperative radiotherapy for prostate cancer
Höcht, S., & Hinkelbein, W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67075-4 · Cited by 9
Blackwell, R. H., Kandabarow, A. M., Gupta, G. N., Harkenrider, M. M., Quek, M. L., & Flanigan, R. C. (2015) · Urology Practice · doi:10.1016/j.urpr.2015.01.001 · Cited by 8
Magnetic resonance spectroscopy: A promising tool for the diagnostics of human prostate cancer?
Kurth, J., DeFeo, E. M., & Cheng, L. L. (2011) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2011.05.016 · Cited by 8
Comparative effectiveness research in localized prostate cancer treatment
Hoffman, R. M., Penson, D. F., Zietman, A. L., & Barry, M. J. (2013) · Journal of Comparative Effectiveness Research · doi:10.2217/cer.13.66 · Cited by 8
Self-citationRisk of hospitalisation after primary treatment for prostate cancer
Williams, S. B., Duan, Z., Chamie, K., Hoffman, K. E., Smith, B. D., Hu, J. C., Shah, J. B., Davis, J. W., & Giordano, S. H. (2016) · British Journal of Urology · doi:10.1111/bju.13647 · Cited by 8
Zyk, N. Y., Garanina, A. S., Plotnikova, E. A., Ber, A. P., Nimenko, E. A., Dashkova, N. S., Uspenskaia, A. A., Shafikov, R. R., Skvortsov, D. A., Petrov, S. A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411327 · Cited by 8
Huyghe, É., Bachaud, J. M., Achard, J. L., Bossi, A., & Droupy, S. (2009) · The French Journal of Urology · doi:10.1016/s1166-7087(09)73368-8 · Cited by 8
Hjälm-Eriksson, M., Lennernäs, B., Ullén, A., Johansson, H., Hugosson, J., Nilsson, S. F., & Brandberg, Y. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2734 · Cited by 8
Kinnaird, W., & Stewart-Lord, A. (2020) · Journal of Radiotherapy in Practice · doi:10.1017/s1460396920000059 · Cited by 8
Prostate Cancer and the Increasing Role of Active Surveillance
Alonzo, D., Mure, A., & Soloway, M. S. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.09.2705 · Cited by 8
Clinical Practice Guidelines in Oncology TM
Engstrom, P. F., Arnoletti, J. P., Benson, A. B., Chen, Y., Choti, M. A., Cooper, H. S., Covey, A. M., Dilawari, R. A., Early, D. S., Enzinger, P. C., et al. (2009) · Cited by 8
Naccarato, A. M. E. P., Reis, L. O., Zani, E. L., Cartapatti, M., & Denardi, F. (2013) · Actas Urológicas Españolas · doi:10.1016/j.acuro.2013.10.012 · Cited by 7
Cheng, Y., Wu, L., Xin, J., Ben, S., Chen, S., Li, H., Zhao, L., Wang, M., Cheng, G., & Du, M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05190-y · Cited by 7
Wootten, A. C., Burney, S., Frydenberg, M., Foroudi, F., Ng, K. T., & Coleman, G. J. (2007) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/j.1743-7563.2007.00134.x · Cited by 7
Xiao, Z. J., Dickey, D. J., Owen, R. J., TULIP, J., & Moore, R. B. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.03.008 · Cited by 7
Ritchey, J. D., Gay, E. G., Spencer, B. A., Miller, D. C., Wallner, L. P., Stewart, A. K., Dunn, R. L., Litwin, M. S., & Wei, J. T. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.04.106 · Cited by 7
Management of the complications of external beam radiotherapy and brachytherapy
Loeb, S., & Nadler, R. B. (2006) · Current Urology Reports · doi:10.1007/s11934-006-0022-0 · Cited by 7
Metadata
- Authors
- Potosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Potosky, A. L.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-09-14
- Volume
- 96
- Issue
- 18
- Pages
- 1358-1367
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2160612556
- Cited by
- 680
- References
- 42
- Citations by year
- 2026: 15 · 2025: 8 · 2024: 16 · 2023: 15 · 2022: 12 · 2021: 15 · 2020: 19 · 2019: 18 · 2018: 26 · 2017: 30 · 2016: 28 · 2015: 32 · 2014: 47 · 2013: 54 · 2012: 55
- FWCI
- 32.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JNCI Journal of the National Cancer Institute (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institutes of Health (n01pc067010-004, n01pc067009-004, n01pc067000-000, n01pc067005-009, n01pc067007-017, N01-PC67010, n01pc067006-000)
- National Cancer Institute (N01-PC-67010, N01-PC-67006, N01 PC-67009, N01 PC67000, N01-PC-67007, N01 PC 67005)
- Topics
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Epidemiology › Multiple and Secondary Primary Cancers
- Keywords
- prostate cancer, radical prostatectomy, external beam radiotherapy, quality of life, erectile dysfunction, urinary incontinence, bowel function, sexual function, long-term treatment outcomes, localized prostate cancer
- MeSH terms
- Aged, Fecal Incontinence, Humans, Erectile Dysfunction, Male, Middle Aged, Prospective Studies, Prostatectomy, Prostatic Neoplasms, Quality of Life, Surveys and Questionnaires, Research Design, Socioeconomic Factors, Urinary Incontinence, Selection Bias, Logistic Models, Radiotherapy, Adjuvant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review